Summary

It is a matter of discussion how to optimize the scientific approach towards the evaluation criteria of the possible effects of the medicinal products on driving and concentration. There is a need of more profound patients` education about these effects. The aim of the study is to conduct а comparative analysis of the European and Bulgarian legislation regarding the required information on the effects of the medicinal products on driving. As the outcome of the study an informational leaflet for patients for the possible effects of the medicinal products on driving was created. The results showed that the legislation is fully synchronized through the EU concerning the information on the short product characteristics and patient leaflet but it is country specific regarding the information on the drug package. We consider that there is a need to emphasize on the role of the pharmacist in Bulgaria as a trustedsource for patients on medicinal products and any additional drug information.